@@ -120,22 +120,39 @@ Guidance on SUS & SUS+ can be found on the [NHS Digital Website](https://digital
120120
121121# Supported Transformations
122122
123- | OMOP Table | SUS APC | SUS OP | SUS AE | SUS CCMDS | COSD | RTDS | SACT |
123+ | OMOP Table | SUS APC | SUS OP | SUS AE | SUS CCMDS | COSD[ < sup >1</ sup > ] ( #supported-cosd-cancer-areas ) | RTDS | SACT |
124124| ------------------------| ---------| -------| ---------| -----------| ------| -------| ------|
125125| * Location* | ✔️ | ✔️ | ✔️ | | ✔️ | ✔️ | ✔️ |
126126| * Person* | ✔️ | ✔️ | ✔️ | | ✔️ | ✔️ | ✔️ |
127127| * Condition Occurrence* | ✔️ | ✔️ | ✔️ | | ✔️ | ✔️ | ✔️ |
128128| * Visit Occurrence* | ✔️ | ✔️ | ✔️ | | | ✔️ | |
129129| * Visit Details* | ✔️ | ✔️ | ✔️ | ✔️ | | | |
130- | * Measurement* | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | | |
130+ | * Measurement* | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | | ✔️ |
131131| * Death* | ✔️ | ✔️ | ✔️ | | ✔️ | | |
132- | * Procedure Occurrence* | ✔️ | ✔️ | ✔️ | | ✔️ | ✔️ | ✔️ |
133- | * Drug Exposure* | | | | | | | |
134- | * Care Site* | ✔️ | ✔️ | ✔️ | | | | |
135- | * Provider* | ✔️ | ✔️ | | | | | |
132+ | * Procedure Occurrence* | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ |
133+ | * Drug Exposure* | | | | | | | ✔️ |
134+ | * Care Site* | ✔️ | ✔️ | ✔️ | | | | ✔️ |
135+ | * Provider* | ✔️ | ✔️ | | | | ✔️ | ✔️ |
136136| * Device Exposure* | ✔️ | ✔️ | ✔️ | ✔️ | | | |
137- | * Observation* | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | | |
138-
137+ | * Observation* | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ | ✔️ |
138+
139+ # Supported COSD Cancer Areas
140+
141+ | COSD Cancer Area | v8 | v9 |
142+ | ------------------------| ---------| -----|
143+ | * Core* | ✔️ | ✔️ |
144+ | * Brain/CNS* | | |
145+ | * Breast* | | |
146+ | * Colorectal* | ✔️ | ✔️ |
147+ | * Gynaecological* | | |
148+ | * Head and Neck* | | |
149+ | * Lung* | ✔️ | ✔️ |
150+ | * Liver* | | |
151+ | * Oesophago-Gastric* | | |
152+ | * Prostate* | | |
153+ | * Sarcoma* | | |
154+ | * Skin* | | |
155+ | * Urological* | | |
139156
140157# Future Aims
141158
0 commit comments